# Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)

> **NCT01023477** · PHASE1,PHASE2 · COMPLETED · sponsor: **Inova Health Care Services** · enrollment: 12 (actual)

## Conditions studied

- Carcinoma, Intraductal, Noninfiltrating
- DCIS
- Ductal Carcinoma In Situ

## Interventions

- **DRUG:** Chloroquine Standard Dose (500mg/week)
- **DRUG:** Chloroquine Low Dose (250mg/week)
- **PROCEDURE:** Breast Biopsy

## Key facts

- **NCT ID:** NCT01023477
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-06-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023477, "Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01023477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*